Robert J. Bitterman - 31 Dec 2025 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Chairman, Pres. & CEO, Director
Signature
/s/ Lisa C. Carson, Attorney-in-fact
Issuer symbol
PHIO
Transactions as of
31 Dec 2025
Net transactions value
+$5,150
Form type
4
Filing time
02 Jan 2026, 16:05:06 UTC
Previous filing
29 Dec 2025
Next filing
06 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bitterman Robert J Chairman, Pres. & CEO, Director C/O PHIO PHARMACEUTICALS CORP., 411 SWEDELAND RD., STE 23-1080, KING OF PRUSSIA /s/ Lisa C. Carson, Attorney-in-fact 02 Jan 2026 0001304395

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common Stock, $.0001 par value Purchase $5,150 +5,000 +1.7% $1.03 291,421 31 Dec 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.